The Latest
-
Trump nominates policy aide Overton to lead FDA
Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.
-
Sponsored by Dell Technologies & NVIDIA
From the clinic to the community: advancing healthcare innovation
See how Dell and NVIDIA are bringing AI-powered solutions to every point of care.
-
FDA seeks feedback on generative AI regulations
The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI for patient care.
-
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.
-
Q&A
How Guardant aims to expand cancer screening with a blood test
Sam Asgarian, Guardant Health’s vice president of clinical development, discusses the progress and challenges of blood-based testing in colorectal and multicancer screening.
-
Baylor Genetics discloses patient information exposed in cyberattack
A third party may have accessed test results and Social Security numbers held by the genetic testing company.
-
Baxter’s interim CFO leaves for Cardinal Health
Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.
-
FDA names second participant in TEMPO digital health pilot
Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.
-
J&J’s Monarch robot wins FDA nod for AI features
The lung bronchoscopy robot adds improvements that include new tools for pre-procedure planning and updated navigation and visual guidance during the procedure.
-
Medtech M&A remains strong in 2026
Recent deals include device manufacturer Integer Holdings selling for $5.7 billion and Tempus agreeing to buy a cancer test maker for $1.5 billion. Read MedTech Dive’s roundup of the top M&A deals so far this year.
Updated Aug. 17, 2026 -
AMS secures shareholder support for planned sale to H.B. Fuller
Buying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.
Updated Aug. 14, 2026 -
Cook Medical discloses cyber incident stemming from a scam
An outside party gained access to some company systems, but the medical device maker found no evidence that sensitive or protected data was obtained and said its operations are running normally.
-
CHAI creates work group to counter frontier AI model cybersecurity risks
CHAI plans to create playbooks to help organizations defend against — and leverage — these powerful systems.
-
Q&A
Inside Senseonics’ commercial overhaul and what’s next
The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.
-
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm
European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.
-
BD fully enrolls trial of resorbable mesh for hernia prevention
BD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and expansion efforts.”
-
Philips authorizes largest shareholder to increase stake to 22%
Philips framed the revised agreement with Exor, the holding company of Italy’s billionaire Agnelli family, as evidence of confidence in its strategy.
-
Abbott, Google to combine glucose data with AI coaching
The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app.
-
Medtronic veteran departs for CEO role at heart valve startup
Bill Shields, who led transcatheter mitral and tricuspid therapies at Medtronic, has joined Versa Vascular, developer of a valve repair treatment.
-
Teledyne inks $1.1B takeover of Varex Imaging
Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.
-
Ortho firms unfazed by Medicare joint replacement changes
Shifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.
-
CMS seeks feedback on faster coverage for breakthrough devices
The proposed “RAPID” pathway could help some new medical devices get national Medicare coverage within months of FDA authorization.
-
Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
-
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
-
Q&A
When does it make sense to build software instead of buy? One health system’s answer.
NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support tool to guide clinicians through treatment. Now, the institutions are commercializing the product so other health systems can use it too.
-
FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.